Proactive Approaches to cGMP Compliance: Insights and Key Takeaways from USFDA Warning Letters to Pharmaceutical Industries Between 2019 and 2024
1. 请及时下载文件确认是否正确, 系统将在 2026-03-17 22:43:06 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1007/s12247-024-09857-3
文献链接: https://link.springer.com/10.1007/s12247-024-09857-3
其他信息:
出版社: Springer Science and Business Media LLC
作者: Gayatri Aglave; Sravani Yerram; Jayasri Devi Patnam; C. S. Ajmal; V. P. Muhammad Nizam; Ramesh Joga; Rajeev Singh Raghuvanshi; Saurabh Srivastava
全文下载地址: https://link.springer.com/content/pdf/10.1007/s12247-024-09857-3.pdf

